LOW SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR BUT NOT BRAIN-DERIVED NEUROTROPHIC FACTOR GENE VAL66MET POLYMORPHISM IS ASSOCIATED WITH DIABETIC RETINOPATHY IN CHINESE TYPE 2 DIABETIC PATIENTS

被引:3
作者
Guo, Min [1 ]
Liu, Huan [1 ]
Li, Shan-Shan [2 ]
Jiang, Fu-Li [3 ]
Xu, Jin-Mei [1 ]
Tang, Ying-Ying [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 4, Dept Endocrinol & Metab Dis, 37 Yiyuan St, Harbin 150001, Peoples R China
[2] Harbin Med Univ, Coll Pharm, Harbin, Peoples R China
[3] Fifth Hosp Heilongjiang Prov, Cardiovasc Dept, Harbin, Peoples R China
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2017年 / 37卷 / 02期
关键词
brain-derived neurotrophic factor; brain-derived neurotrophic factor gene Val66Met polymorphism; Type 2 diabetes mellitus; diabetic retinopathy; RETINAL GANGLION-CELLS; FACTOR BDNF; RECEPTOR TRKB; PLASMA-LEVELS; MULLER CELLS; RISK-FACTORS; MELLITUS; RATS; PREVALENCE; EXPRESSION;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/Purpose: The aim of our research was to investigate the potential role of brain-derived neurotrophic factor (BDNF) in diabetic retinopathy (DR). Measurement of serum circulating levels of BDNF and analysis of polymorphism of BDNF gene (Val66Met) were applied and compared with diabetic patients without DR. Methods: From February 2014 and March 2015, all eligible patients with Type 2 diabetic mellitus at our hospital were consecutively recruited (N = 404). Their serum BDNF levels were detected by enzyme-linked immunosorbent assay. BDNF val66met polymorphism genotyping was conducted according to the laboratory's standard protocol. At baseline, demographic and clinical data were taken. The relationship of BDNF with DR was investigated with the use of logistic regression models. Receiver operating characteristic curves were used to test the overall accuracy of BDNF and other markers. Results: Diabetic patients with DR and vision-threatening DR had significantly lower BDNF levels on admission (P < 0.0001 both). The BDNF genotyping results showed that there was no difference between the diabetic patients with DR and those without DR. Multivariate logistic regression analysis adjusted for common risk factors showed that serum BDNF levels were independent risk factors for DR (odds ratio = 0.86; 95% confidence interval [CI]: 0.80-0.92; P < 0.0001) and vision-threatening DR (odds ratio = 0.79; 95% CI: 0.75-0.85; P < 0.0001). Brain-derived neurotrophic factor improved the area under the receiver operating characteristic curve of the diabetes duration for DR from 0.69 (95% CI: 0.60-0.76) to 0.85 (95% CI: 0.79-0.90; P < 0.0001) and for vision-threatening DR from 0.77 (95% CI: 0.67-0.87) to 0.86 (95% CI: 0.80-0.92; P < 0.0001). Conclusion: The present study demonstrated that, rather than Val66Met polymorphism, decreased serum levels of BDNF were associated with DR and vision-threatening DR in Chinese Type 2 diabetic patients, suggesting a possible role of BDNF in the pathogenesis of DR complications.
引用
收藏
页码:350 / 358
页数:9
相关论文
共 33 条
[1]   Evaluation of serum brain-derived neurotrophic factor levels in Type 2 diabetes mellitus patients with and without depressive symptoms [J].
Agilli, Mehmet ;
Aydin, Fevzi Nuri ;
Kurt, Yasemin Gulcan ;
Cayci, Tuncer .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2015, 47 (04)
[2]  
[Anonymous], 1991, OPHTHALMOLOGY, V98, P786
[3]   Relationship between Levels of Brain-Derived Neurotrophic Factor and Metabolic Parameters in Patients with Type 2 Diabetes Mellitus [J].
Boyuk, Banu ;
Degirmencioglu, Serife ;
Atalay, Hande ;
Guzel, Savas ;
Acar, Ayse ;
Celebi, Aslan ;
Ekizoglu, Ismail ;
Simsek, Caglar .
JOURNAL OF DIABETES RESEARCH, 2014, 2014 :1-6
[4]   BDNF regulates GLAST and glutamine synthetase in mouse retinal Muller cells [J].
Dai, Min ;
Xia, Xiao-Bo ;
Xiong, Si-Qi .
JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (02) :596-603
[5]   Neural guidance molecules regulate vascular remodeling and vessel navigation [J].
Eichmann, A ;
Makinen, T ;
Alitalo, K .
GENES & DEVELOPMENT, 2005, 19 (09) :1013-1021
[6]  
FEMAN SS, 1995, INVEST OPHTH VIS SCI, V36, P174
[7]   Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance [J].
Fujinami, Aya ;
Ohta, Kiyoe ;
Obayashi, Hiroshi ;
Fukui, Michiaki ;
Hasegawa, Goji ;
Nakamura, Naoto ;
Kozai, Hana ;
Imai, Saeko ;
Ohta, Mitsuhiro .
CLINICAL BIOCHEMISTRY, 2008, 41 (10-11) :812-817
[8]   Preliminary Findings Regarding Proinflammatory Markers and Brain-Derived Neurotrophic Factor Among Adolescents with Bipolar Spectrum Disorders [J].
Goldstein, Benjamin I. ;
Collinger, Katelyn A. ;
Lotrich, Francis ;
Marsland, Anna L. ;
Gill, Mary-Kay ;
Axelson, David A. ;
Birmaher, Boris .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (05) :479-484
[9]   Protective Effects of Adeno-associated Virus Mediated Brain-derived Neurotrophic Factor Expression on Retinal Ganglion Cells in Diabetic Rats [J].
Gong, Yan ;
Chang, Zhan-Ping ;
Ren, Ruo-Tong ;
Wei, Shi-hui ;
Zhou, Huan-Fen ;
Chen, Xiao-fei ;
Hou, Bao-ke ;
Jin, Xin ;
Zhang, Mao-nian .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2012, 32 (03) :467-475
[10]   Brain-derived neurotrophic factor (BDNF) and type 2 diabetes [J].
Krabbe, K. S. ;
Nielsen, A. R. ;
Krogh-Madsen, R. ;
Plomgaard, P. ;
Rasmussen, P. ;
Erikstrup, C. ;
Fischer, C. P. ;
Lindegaard, B. ;
Petersen, A. M. W. ;
Taudorf, S. ;
Secher, N. H. ;
Pilegaard, H. ;
Bruunsgaard, H. ;
Pedersen, B. K. .
DIABETOLOGIA, 2007, 50 (02) :431-438